GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

Ventyx Biosciences' VTX3232 showed promising anti-inflammatory Phase 2 results, but financial risks remain. Click here to ...

Alabama Attorney General Steve Marshall says that a Cullman County Circuit Court approved his request for a temporary ...

Mounjaro is priced at Rs 3,500 per 2.5 mg single-dose vial and Rs 4,375 per 5 mg single-dose vial, adding up to anywhere ...

Wegovy, the blockbuster weight-loss drug launched in June, is set to get cheaper in India. Danish drugmaker Novo Nordisk has ...

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

The gastrointestinal safety profiles were similar between dulaglutide, tirzepatide, and semaglutide among patients with type 2 diabetes.